A new link between cancer and inflammation?

Journal of Hepatology

Volumn 51, Issue 1, 2009, Pages 230-232

  Longerich, Thomas ^a   Schirmacher, Peter ^a  

^a UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BETA CATENIN; GLYCOPROTEIN GP 130; INTERLEUKIN 6; STAT3 PROTEIN;

ARTICLE; EPITHELIUM TUMOR; GENE DELETION; GENE MUTATION; GENE SEQUENCE; HEPATITIS; HEPATOCELLULAR ADENOMA; HUMAN; IMMUNOHISTOCHEMISTRY; LIVER CELL; LIVER CELL CARCINOMA; LIVER TUMOR; PRIORITY JOURNAL; PROTEIN EXPRESSION;

EID: 67349226343     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jhep.2009.03.004     Document Type: Article

References (9)

1. Rebouissou S., Amessou M., Couchy G., Poussin K., Imbeaud S., Pilati C., et al. Frequent in-frame somatic deletions activate gp130 in inflammatory hepatocellular tumours. Nature 457 (2009) 200-204
2. Paradis V., Benzekri A., Dargere D., Bieche I., Laurendeau I., Vilgrain V., et al. Telangiectatic focal nodular hyperplasia: a variant of hepatocellular adenoma. Gastroenterology 126 (2004) 1323-1329
3. Rebouissou S., Bioulac-Sage P., and Zucman-Rossi J. Molecular pathogenesis of focal nodular hyperplasia and hepatocellular adenoma. J Hepatol 48 (2008) 163-170
4. Rebouissou S., Imbeaud S., Balabaud C., Boulanger V., Bertrand-Michel J., Terce F., et al. HNF1alpha inactivation promotes lipogenesis in human hepatocellular adenoma independently of SREBP-1 and carbohydrate-response element-binding protein (ChREBP) activation. J Biol Chem 282 (2007) 14437-14446
5. Zucman-Rossi J., Jeannot E., Nhieu J.T., Scoazec J.Y., Guettier C., Rebouissou S., et al. Genotype-phenotype correlation in hepatocellular adenoma: new classification and relationship with HCC. Hepatology 43 (2006) 515-524
6. Breuhahn K., Vreden S., Haddad R., Beckebaum S., Stippel D., Flemming P., et al. Molecular profiling of human hepatocellular carcinoma defines mutually exclusive interferon regulation and Insulin-Like Growth Factor II overexpression. Cancer Res 64 (2004) 6058-6064
7. Wolfel T., Hauer M., Schneider J., Serrano M., Wolfel C., Klehmann-Hieb E., et al. A p16INK4a-insensitive CDK4 mutant targeted by cytolytic T lymphocytes in a human melanoma. Science 269 (1995) 1281-1284
8. Schwitalle Y., Kloor M., Eiermann S., Linnebacher M., Kienle P., Knaebel H.P., et al. Immune response against frameshift-induced neopeptides in HNPCC patients and healthy HNPCC mutation carriers. Gastroenterology 134 (2008) 988-997
9. Bioulac-Sage P., Rebouissou S., Thomas C., Blanc J.F., Saric J., Sa Cunha A., et al. Hepatocellular adenoma subtype classification using molecular markers and immunohistochemistry. Hepatology 46 (2007) 740-748